PTGS2 and neoplasm: Through network pharmacological research, 6 key targets including IL6, VEGFA, JUN, TP53, 1L1B and PTGS2 were screened as important anti-PTC targets of SS. Through the construction of SS “drug-component-disease” target network and target gene PPI network, it was revealed that the target sites coordinated the process of proliferation, apoptosis, differentiation and metabolism to inhibit tumor metastasis through interaction.